Evidence map›Paper›PMID 27565164›Full record

ArticleInflammation2016

Intravenous Glutamine Administration Modulates TNF-α/IL-10 Ratio and Attenuates NFkB Phosphorylation in a Protein Malnutrition Model.

Andressa Cristina Antunes Santos, Carolina Argondizo Correia, Dalila Cunha de Oliveira, Amanda Nogueira-Pedro, Primavera Borelli, Ricardo Ambrosio Fock

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Glutamine metabolism in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A2M inhibits inflammatory mediators of chondrocytes by blocking IL-1β/NF-κB pathway.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  8. Malnutrition is associated with hyperinflammation and immunosuppression in COVID-19 patients: A prospective observational study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2021
    Observational
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andressa Cristina Antunes SantosDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil.
Carolina Argondizo CorreiaDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil.
Dalila Cunha de OliveiraDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil.
Amanda Nogueira-PedroDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil.
Primavera BorelliDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil.
Ricardo Ambrosio FockDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, 05508-000, Brazil. hemato@usp.br.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein malnutrition (PM) is a major public health problem in developing countries, affecting the inflammatory response and increasing susceptibility to opportunistic infections. For this reason, an adequate nutritional intervention can improve the quality of life of patients. Glutamine (GLN) is a nonessential amino acid, but can be considered "conditionally essential" for macrophage function in stress situations, in which it plays a role in the improvement of the inflammatory response. Concerning this issue, in the current study, it was of interest to evaluate some biological aspects of peritoneal cells from a protein malnutrition (PM) mouse model challenged with lipopolysaccharide (LPS) and treated intravenously with GLN. Two-month-old male Balb/c mice were subjected to a low-protein diet (2 % protein) and stimulated intravenously with LPS 1 h prior to the injection of 0.75 mg/kg GLN. Malnourished animals showed a reduced number of total peritoneal cells. Malnourished animals stimulated with LPS or LPS plus GLN did not show differences in peritoneal cell counts; however, the control group showed increased cellularity after LPS stimulus, which was reversed after GLN injection. Further, in the animals from both groups stimulated with LPS, GLN decreased the circulating levels of TNF-α and the levels of TNF-α produced by peritoneal cells; additionally, GLN decreased the IL-10 circulating levels in the malnourished animals stimulated with LPS. In addition, peritoneal cells of the control and malnourished groups stimulated with LPS showed a negative modulation of the NFkB signaling pathway after GLN injection. In conclusion, this study shows that GLN has the capacity to reduce TNF-α synthesis as well as to act as a negative regulator of NFkB phosphorylation, leading to a positive outcome in the control of TNF-α production.

Indexed as

AnimalsDisease Models, AnimalGlutamineInterleukin-10MiceMice, Inbred BALB CNF-kappa BPeritoneumPhosphorylationProtein-Energy MalnutritionTumor Necrosis Factor-alphaGlutamineInterleukin-10NF-kappa BTumor Necrosis Factor-alphaglutaminelpsmacrophagesprotein malnutritiontnf-α and nfkB

Identifiers

PMID27565164
OpenAlexW2513234098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.